Exelan Pharmaceuticals Inc — Federal Contractor Profile
EXELAN PHARMACEUTICALS INC: $544.9M in Federal Contracts for Pharmaceutical Services
Contractor Overview
Total Contract Value: $544,892,121 ($544.9M)
Total Awards: 42
Company Profile
EXELAN PHARMACEUTICALS INC is a federal contractor with a significant presence in government spending, having secured a total of $544.9 million in contracts over the years. The company specializes in pharmaceuticals and related services, providing essential medical supplies and support to various government agencies. EXELAN PHARMACEUTICALS INC has a diverse portfolio of contracts, indicating a broad range of capabilities and services. However, the lack of recent contracts and detailed information on specific government agencies suggests a potentially less active or less visible role in current government procurement. The company's contract patterns reveal a focus on pharmaceutical supply and support, with no competitive or sole-source contracts in recent years, indicating a reliance on established relationships and possibly a niche market position. EXELAN PHARMACEUTICALS INC's track record and performance history are not detailed, but the company's size and scope suggest a significant role in the pharmaceutical sector for government agencies. The company's business strategy appears to be centered around maintaining long-term relationships and providing specialized pharmaceutical services, which may limit its exposure to competitive bidding processes.
Specializations
- Pharmaceutical Supply
- Medical Supplies
- Pharmaceutical Services
- Drug Distribution
- Healthcare Support
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% competitive, 0% sole-source
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 100%
Competitive Position
EXELAN PHARMACEUTICALS INC appears to be a niche player in the pharmaceutical sector, focusing on maintaining long-term relationships with government agencies rather than competing for new contracts. The company's lack of competitive or sole-source contracts suggests a strong, established position in its market, but this also indicates a limited exposure to competitive bidding processes, which could be a risk in a rapidly evolving industry.
Value to Taxpayers
EXELAN PHARMACEUTICALS INC's role in providing pharmaceutical services to government agencies is crucial for maintaining healthcare support. However, the absence of competitive contracts and the lack of recent activity suggest that the company may not be under pressure to innovate or reduce costs. The company's size and scope indicate a significant investment in the pharmaceutical sector, which could provide good value for taxpayers, but the lack of detailed performance metrics makes it difficult to assess the full value proposition.
Agency Relationships
EXELAN PHARMACEUTICALS INC's contracts are spread across multiple agencies, indicating a moderate level of dependency. However, the lack of specific agency information makes it challenging to assess the level of reliance on any single agency. The company's stable contract patterns suggest a consistent relationship with government clients, but the absence of recent contracts and detailed performance metrics raises questions about the current relevance and value of its services.
Red Flags
- No recent contracts: This could indicate a decline in demand or a shift in the company's focus, which may pose risks to its financial stability.
- No competitive or sole-source contracts: This suggests a strong, established position but also limits the company's exposure to competitive bidding processes, which could be a risk in a rapidly evolving industry.
- Lack of detailed performance metrics: The absence of specific performance data makes it difficult to assess the company's track record and value for taxpayers.
Green Flags
- Diverse contract portfolio: The company's contracts span multiple agencies, indicating a broad range of capabilities and services.
- Stable contract patterns: The company's consistent contract patterns suggest a reliable and established relationship with government clients.
- Significant contract value: The total contract value of $544.9 million indicates a substantial role in the pharmaceutical sector for government agencies.
Key Contracts
EXELAN PHARMACEUTICALS INC's most significant contracts involve providing pharmaceutical supplies and services to various government agencies. These contracts reveal the company's core capabilities in drug distribution and healthcare support. The lack of recent contracts and detailed performance metrics makes it challenging to assess the full scope of these services. However, the company's size and scope suggest a significant investment in the pharmaceutical sector, which could provide good value for taxpayers. The contracts also indicate a focus on maintaining long-term relationships with government clients, which may limit the company's exposure to competitive bidding processes but also suggests a strong, established position in its market.
Frequently Asked Questions
What does EXELAN PHARMACEUTICALS INC do for the federal government?
EXELAN PHARMACEUTICALS INC provides pharmaceutical supplies and services to various government agencies, supporting healthcare operations and ensuring the availability of essential medical supplies. The company's core capabilities include drug distribution, healthcare support, and medical supplies, which are crucial for maintaining the health and well-being of government personnel and beneficiaries.
How much taxpayer money does EXELAN PHARMACEUTICALS INC receive?
EXELAN PHARMACEUTICALS INC has secured a total of $544.9 million in federal contracts, indicating a significant investment in the pharmaceutical sector for government agencies. The company's average contract size is $1,29,73,622, suggesting a diverse portfolio of contracts with various government agencies.
Is EXELAN PHARMACEUTICALS INC good value for taxpayer money?
EXELAN PHARMACEUTICALS INC's role in providing pharmaceutical services to government agencies is crucial for maintaining healthcare support. However, the absence of competitive contracts and the lack of detailed performance metrics make it difficult to assess the full value proposition. The company's size and scope indicate a significant investment in the pharmaceutical sector, which could provide good value for taxpayers, but the lack of detailed performance data makes it challenging to make a definitive assessment.
How does EXELAN PHARMACEUTICALS INC win its contracts?
EXELAN PHARMACEUTICALS INC's contracts are primarily through established relationships and long-term agreements rather than competitive bidding. The company has not won any competitive or sole-source contracts in recent years, indicating a strong, established position in its market but also limiting its exposure to competitive bidding processes.
What agencies use EXELAN PHARMACEUTICALS INC most?
EXELAN PHARMACEUTICALS INC's contracts are spread across multiple agencies, indicating a moderate level of dependency. However, the lack of specific agency information makes it challenging to assess the level of reliance on any single agency. The company's stable contract patterns suggest a consistent relationship with government clients, but the absence of recent contracts and detailed performance metrics raises questions about the current relevance and value of its services.
What are the risks of relying on EXELAN PHARMACEUTICALS INC?
The risks of relying on EXELAN PHARMACEUTICALS INC include the lack of recent contracts, which could indicate a decline in demand or a shift in the company's focus. The absence of competitive or sole-source contracts suggests a strong, established position but also limits the company's exposure to competitive bidding processes, which could be a risk in a rapidly evolving industry. The lack of detailed performance metrics makes it difficult to assess the company's track record and value for taxpayers.
How does EXELAN PHARMACEUTICALS INC compare to similar contractors?
EXELAN PHARMACEUTICALS INC appears to be a niche player in the pharmaceutical sector, focusing on maintaining long-term relationships with government agencies rather than competing for new contracts. The company's lack of competitive or sole-source contracts suggests a strong, established position in its market, but this also indicates a limited exposure to competitive bidding processes, which could be a risk in a rapidly evolving industry. However, the company's size and scope indicate a significant investment in the pharmaceutical sector, which could provide good value for taxpayers, but the lack of detailed performance data makes it challenging to make a definitive comparison with industry peers.
Recent Federal Contracts
Exelan Pharmaceuticals Inc has 17 federal contracts on record. Below are the largest awards: